)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Lincoln Pharmaceuticals
Lincoln Pharmaceuticals (531633) investor relations material
Lincoln Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary13 Aug, 2026
Executive summary
Consolidated net profit for Q1 FY27 reached Rs. 36.23 crore, up 30.90% year-over-year, with total income rising 19.02% to Rs. 201.55 crore and EBITDA increasing 32.29% to Rs. 51.70 crore.
The company targets Rs. 1,000 crore revenue over the next three years, aiming for 15-18% annual growth, driven by strong performance in cardiac, diabetic, dermatology, and ENT segments.
Exports span 60+ countries, with plans to expand to 90 countries in 2-3 years, supported by regulatory approvals in Canada, EU, and Australia.
Financial highlights
Q1 FY27 total income: Rs. 201.55 crore (up 19.02% YoY); EBITDA: Rs. 51.70 crore (up 32.29% YoY); net profit: Rs. 36.23 crore (up 30.90% YoY); EPS: Rs. 18.09.
FY26 total income: Rs. 704.48 crore (up 9.10% YoY); EBITDA: Rs. 131.14 crore (up 5.78% YoY); net profit: Rs. 87.89 crore (up 6.74% YoY); dividend of Rs. 1.80 per share recommended.
Standalone and consolidated results for Q1 FY27 show similar trends, with revenue from operations at Rs. 177.28 crore and net profit at Rs. 36.23 crore.
Outlook and guidance
Management reiterates focus on operational efficiency, portfolio expansion, and disciplined execution to achieve Rs. 1,000 crore revenue and sustainable growth.
Plans to expand presence in regulated and semi-regulated markets, leveraging recent regulatory approvals and manufacturing capabilities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lincoln Pharmaceuticals
- Sales grew 23%, while Khatraj delays constrained results and the expansion outlook.531633
Q4 96/97 - Profit improved YoY, but delayed expansion and recession kept results well below plan.531633Q4 97/98
- Sales and profit grew, but operating cash flow swung negative.531633Q4 98/99
- FY2000 sales and net profit rose; exports fell and no dividend was proposed.531633Q4 99/00
- Sales rose to Rs 3,356.16 lacs and net profit to Rs 144.24 lacs in FY03.531633Q4 02/03
- Sales and net profit advanced as expansion plans faced competition and rising costs.531633Q4 03/04
- Sales grew, but profit fell; a 12% dividend and cautious growth plans followed.531633Q4 04/05
- Sales rose 49% as PAT grew, with new products and job work targeted for further growth.531633Q4 05/06
- Sales rose 12.25% as PAT increased to Rs 304.76 lakh amid competitive pressure.531633Q4 06/07
- Sales rose 36% as PAT climbed to ₹466.26 lakh; expansion plans faced competition and cost pressure.531633Q4 07/08
Next Lincoln Pharmaceuticals earnings date
Q2 202712 Nov, 2026
Lincoln Pharmaceuticals
Next Lincoln Pharmaceuticals earnings date
Q2 202712 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage